SUNPHARMA - IntraDay Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

📈 Intraday Trade Analysis for SUNPHARMA (Sun Pharmaceutical Industries Ltd.)

Trade Rating: 4.1

This score reflects a strong intraday setup supported by bullish momentum, solid fundamentals, and technical resilience—though recent profit contraction and valuation caution temper the outlook.

🔍 Technical & Volume Insights

RSI at 58.6: Bullish zone, indicating upward momentum but not yet overbought.

MACD at +5.11: Positive crossover, confirming bullish trend continuation.

Price above DMA 50 (₹1,692) and DMA 200 (₹1,702): Indicates strength and trend support.

Volume: 14.5L vs Avg 1Wk: 14.9L: Near average, showing steady intraday interest.

📊 Fundamental Snapshot

ROCE (20.2%) & ROE (16.9%): Strong profitability metrics.

Debt-to-Equity (0.03): Very low leverage—financially sound.

PEG Ratio (1.78): Slightly elevated, suggesting moderate overvaluation.

EPS (₹45.6) vs P/E (35.8): Fairly valued relative to industry PE (34.0).

Qtr Profit Var: -13.1%: Recent dip in earnings—watch for sentiment shifts.

🛒 Optimal Buy Zone (If Entering Today)

Buy Range: ₹1,705–₹1,708

Near intraday support and VWAP, offering a low-risk entry if price stabilizes.

🎯 Exit Strategy

Scenario Entry Trigger Target Levels Stop Loss

Bullish Momentum Buy above ₹1,714.5 (5-min candle close) ₹1,719 → ₹1,729 ₹1,710

Pullback Entry Buy near ₹1,705 ₹1,710 → ₹1,714 ₹1,699

If Already Holding Exit if price breaks below ₹1,705 or fails to hold ₹1,710 Trail profits above ₹1,714.5 SL at ₹1,705

⚠️ Trade Caution

Momentum is strong, but RSI nearing 60 suggests possible short-term exhaustion.

Avoid chasing price above ₹1,729 without volume confirmation.

Monitor 5-min candles for breakout or reversal signals.

Would you like a swing trade setup or a sector comparison for SUNPHARMA next?

Edit in a page